By Capital District Times |
Aug 15, 2024
House Republican leaders have voiced strong opposition to the Biden-Harris Administration's recent announcement of prescription drug price controls mandated by the "Inflation Reduction Act." The statement, issued by House Republican Conference Chairwoman Elise Stefanik, Speaker Mike Johnson, Majority Leader Steve Scalise, and Majority Whip Tom Emmer, criticizes the policy as detrimental to both patients and the pharmaceutical industry.